acute uncomplicated lower urinary tract infection
Conditions
Interventions
Control group:Levofloxacin tablets, twice a day, one tablet at a time, with a treatment period of 7 days
Test group 1:Longqing tablets, twice a day, six tablet at a time, with a treatment period of 7 days
Test group 2:Levofloxacin + Longqing tablets, administered with an interval of 30min for 7 days
Sponsors
Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) 18-80 years old; (2) Diagnosed as acute uncomplicated lower urinary tract infection or Xiajiao Shire syndrome, the duration of the illness < 72 hours; (3) No antibiotics were received within 48 hours prior to inclusion; (4) Agree to participate in this clinical trial.
Exclusion criteria
Exclusion criteria: (1) Participated in other clinical trials within 3 months; (2) Allergic to Longqing tablets or quinolones; (3) Previously insensitive to levofloxacin; (4) Complicated urinary tract infection; (5) Unable to cooperate because of severe heart, lung, liver and kidney diseases, tumors or other serious or progressive diseases of the system and mental disorders; (6) Combined use of other antibacterial agents; (7) Subjiects with Ganyu Qizhi, Pixu Qixian, Shenyang Shuaibei, Shenyin Kuihao, or Tixu Weihan; (8) Breastfeeding women or recent family planning
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comprehensive curative effect cure rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical symptoms cure rate;Laboratory index;Assessment of the severity of the disease;OABSS score;Disappearance rate of single symptom;Recurrence rate of patients with comprehensive cure after 1 month; | — |
Countries
China
Contacts
Public ContactZhiqiang Chen
Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology
Outcome results
None listed